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Abstract
Background:  Human  obesity  is  associated  with  a  proinﬂammatory  state  and  an  elevated  level
of mediators,  such  as  C-reactive  protein  (CRP).
Objectives:  To  establish  CRP  levels  as  baseline  preoperative  values  and  then  at  6  months  after
bariatric surgery,  as  well  as  to  determine  the  changes  in  weight,  body  mass  index  (BMI),  leuko-
cytes, and  glycemia.
Materials  and  methods:  An  observational,  analytical,  retrospective,  longitudinal,  and  open
study was  conducted.  Serum  CRP  values  were  measured  in  36  adults  presenting  with  morbid
obesity, and  their  baseline  relation  to  weight,  BMI,  leukocytes,  and  glycemia  was  determined;
the relation  to  the  same  parameters  was  established  again,  6  months  after  bariatric  surgery.
Results: The  mean  and  standard  deviation  of  preoperative  and  postoperative  CRP  (mg/L)
was 1.15  ±  0.86  and  0.34  ±  0.28,  respectively  with  p  <  0.0001;  weight  (kg)  112.10  ±  22.91  and
84.82 ±  17.11,  p  =  0.0443;  BMI  (kg/m2)  42.48  ±  5.97  and  32.2  ±  4.79,  p  =  0.0988;  glucose  (mg/dL)
100.58 ±  17.82  and  87.11  ±  8.49,  p  <  0.0001,  and  leukocytes  (×  103/mm3)  8.62  ±  1.69  and
6.99 ±  1.56,  p  =  0.3192.
Baseline  CRP  only  correlated  with  weight  and  BMI  (p  =  0.047  and  p  =  0.027  respectively)  and
there was  no  correlation  between  postoperative  CRP  and  the  evaluated  parameters.
Conclusions:  Preoperative  CRP  had  a  signiﬁcant  lineal  relation  to  weight  and  body  mass  index.
Patients who  underwent  bariatric  surgery  had  a  signiﬁcant  decrease  in  CRP,  weight,  and  fasting
glucose at  6  months  after  surgery.
©  2014  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  All
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Nivel  de  proteína  C  reactiva  en  pacientes  con  obesidad  mórbida  antes  y  después
de  cirugía  bariátrica
Resumen
Antecedentes:  La  obesidad  humana  se  asocia  a  un  estado  proinﬂamatorio  reﬂejado  en  elevación
de marcadores  como  la  proteína  C  reactiva  (PCR).
Objetivos:  Establecer  los  valores  de  PCR  basales  y  a  6  meses  de  la  cirugía  bariátrica,  así  como
los cambios  en  peso,  índice  de  masa  corporal  (IMC),  leucocitos  y  glucemia.
Materiales  y  métodos:  Se  realizó  un  estudio  observacional,  analítico,  retrospectivo,  longitudi-
nal y  abierto.  Se  midieron  los  valores  de  PCR  sérica  y  su  relación  con  el  peso,  IMC,  leucocitos  y
glucemia  de  manera  basal  y  6  meses  posteriores  a  cirugía  bariátrica  en  36  adultos  con  obesidad
mórbida.
Resultados:  La  media  ±  desviación  estándar  de  la  PCR  pre  y  posoperatorio  (mg/l)  fue
1.15 ±  0.86  y  0.34  ±  0.28,  respectivamente,  con  p  <  0.0001;  peso  (kg)  112.10  ±  22.91  y
84.82 ±  17.11,  p  =  0,0443;  IMC  (kg/m2)  42.48  ±  5.97  y  32.2  ±  4.79,  p  =  0.0988;  glucosa  (mg/dl)
100.58 ±  17.82  y  87.11  ±  8.49,  p  <  0.0001,  y  leucocitos  (×  103/mm3)  8.62  ±  1.69  y  6.99  ±  1.56,
p =  0.3192.
La  PCR  basal  solo  correlacionó  con  el  peso  e  IMC  (p  =  0.047  y  p  =  0.027,  respectivamente)  y
no hubo  correlación  entre  la  PCR  posoperatoria  y  ninguno  de  los  parámetros  evaluados.
Conclusiones:  La  PCR  tiene  una  relación  lineal  signiﬁcativa  en  el  preoperatorio  con  el  peso  y
el IMC.  Los  pacientes  sometidos  a  cirugía  bariátrica  presentaron  disminución  signiﬁcativa  en  la
PCR, el  peso  y  la  glucemia  en  ayuno  a  los  6  meses  posterior  a  la  cirugía.
© 2014  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Todos los  derechos  reservados.
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Obesity  is  currently  a  pandemia.  It  is  estimated  that  in  20  ye-
ars  obesity  and  its  related  comorbidities  will  be  the  num-
ber  one  health  problem  worldwide.  From  1960  to  2000  the
prevalence  of  obesity  more  than  doubled,  augmenting  from
13.3%  to  30.9%.  The  prevalence  of  morbid  obesity  increased
from  2.9%  to  4.7%  between  the  years  1988  and  2000.1 Many
studies  show  that  obese  individuals  have  a  50  to  100%  higher
risk  for  death  due  to  any  cause,  especially  cardiovascular
events,  compared  with  normal  weight  individuals.  There  is
a  mean  2  to  5-year  decrease  in  the  life  expectancy  of  a mod-
erately  obese  person,  and  that  decrease  is  8  to  13  years  for
individuals  with  a  body  mass  index  (BMI)  above  45.2
It  is  a  known  fact  that  the  results  of  the  medical
treatment  of  obesity  are  not  very  encouraging.3 The  United
States  National  Health  Institute  found  that  95%  of  the
patients  that  begin  with  weight  loss  with  or  without  modi-
fying  their  habits,  return  to  their  usual  weight  2  years  from
the  time  of  their  maximum  weight  loss.  Because  of  this,  two
long-term  weight  control  treatments  are  recommended:
vertical  banded  gastroplasty  or  gastric  cuff  and  Roux-en-Y
gastric  bypass.4
Human  obesity  is  associated  with  a  chronic  low-grade
proinﬂammatory  state  manifested  by  an  increase  in  the
plasma  levels  of  the  interleukin  6  (IL-6)  and  tumor  necrosis
factor  alpha  (TNF) inﬂammatory  cytokines,  as  well  as  ele-
vated  acute  phase  enzymes  and  high  levels  of  endothelial
cell  dysfunction  and  activation  markers.  Weight  loss  atten-
uates  this  proinﬂammatory  state.5
Likewise,  obesity  is  associated  with  diminished  longevity
and  increased  morbidity  due  to  a  large  number  of  illnesses
c
c
much  as  type  2  diabetes  mellitus  (DM2),  cardiovascular  dis-
ases,  high  blood  pressure,  and  hyperlipidemia.6 The  basis
f  the  relation  between  obesity  and  the  development  of
hese  diseases  is  not  very  clear.  An  increase  in  the  circulat-
ng  levels  of  inﬂammatory  mediators  has  been  demonstrated
n  obese  individuals.  These  ﬁndings  are  interesting  in  the
ontext  of  a  pathophysiologic  role  suggested  for  the  inﬂam-
atory  mediators  in  the  development  of  obesity-related
orbidity,  such  as  insulin  resistance  and  cardiovascular
iseases.7
Massive  accumulation  of  body  fat  in  morbid  obesity
as  been  associated  with  hyperinsulinemia  and  insulin
esistance  (IR),  which  appear  to  be  the  cornerstones  of
besity-related  metabolic  syndrome.  Obesity  and  IR  are
ssociated  with  high  marker  levels  of  circulating  endothelial
ysfunction,  such  as  the  intercellular  adhesion  molecule-
 (ICAM-1),  soluble  E  selectin,  and  the  von  Willebrand
actor,  as  well  as  endothelial  vasoactive  peptides,  like
ngiotensinogen  and  the  angiotensin-converting  enzyme
ACE).8
In  addition,  there  is  evidence  suggesting  the  role  of
ow-grade  inﬂammation  as  the  association  factor  between
besity  and  IR,  with  endothelial  dysfunction.  An  increase  in
he  levels  of  serum  inﬂammatory  markers  such  as  C-reactive
rotein  (CRP)  has  been  reported  in  obese  subjects  and  it
as  been  associated  with  the  degree  of  IR  and  endothelial
ysfunction.  Numerous  mechanisms  for  explaining  the  low-
rade  inﬂammation  related  to  obesity  have  been  suggested.8
irst,  fatty  tissue  is  an  important  source  of  proinﬂammatory
ytokines,  such  as  TNF and  IL-6,  and  of  anti-inﬂammatory
ytokines,  such  as  adiponectin.  Second,  IR  can  cause  inﬂam-
ation  by  interfering  with  the  anti-inﬂammatory  effect  of
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Table  1  Preoperative  Variables  (n  =  36).
Variable  Number  of  patients
Women  32
Men 4
Surgery
Gastric by-pass  26
Sleeve  gastrectomy  10
Mean  ±  standard  deviation
Age  (years)  37  ±  7.94
CRP (mg/l)  1.15  ±  0.86
Weight  (kg)  112.1  ±  22.91
Height  (m)  1.62  ±  0.08
BMI (kg/m2)  42.48  ±  5.97
Glucose  (mg/dl)  100.58  ±  17.82
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nsulin.  And  ﬁnally,  obesity  is  characterized  by  oxidative
tress,  mainly  through  excessive  ingestion  of  macronutri-
nts  or  through  an  increase  in  the  metabolic  rate,  which
an  be  partially  responsible  for  the  inﬂammatory  response.
n  fact,  a  glucose  or  lipid  load  in  normal  or  obese  subjects
auses  an  increase  in  inﬂammation  and  a  decrease  in  vascu-
ar  reactivity.8 Controversially,  dietary  restriction  in  obese
atients  causes  a  signiﬁcant  reduction  in  oxidative  stress  and
nﬂammation.9
Van  Dielen  et  al.  demonstrated  a  correlation  between  the
evels  of  the  inﬂammatory  mediators,  the  acute  phase  pro-
eins,  and  body  weight.  Even  though  a  causal  relation  has
ot  been  found,  it  suggests  that  elevated  levels  of  CRP  are
rognostic  for  the  development  of  cardiovascular  disease.
ther  proteins  related  to  inﬂammation,  such  as  the  plas-
inogen  activator  inhibitor-1  and  the  macrophage  migration
nhibitory  factor,  are  associated  with  the  development  of
besity-related  diseases.10
It  has  been  suggested  that  weight  loss  after  bariatric
urgery  causes  a  reduction  of  metabolic  stress,  which  in  turn
educes  the  inﬂammatory  markers  and  acute  phase  proteins
n  subjects  presenting  with  morbid  obesity. 11
During  weight  loss  from  restrictive  gastric  surgery,  there
s  an  eventual  decrease  in  practically  all  the  measured
nﬂammatory  mediators;  and  it  has  been  shown  that  after
hat,  obesity  surgery  signiﬁcantly  reduces  the  comorbidi-
ies  related  to  obesity,  such  as  cardiovascular  disease  and
iabetes  mellitus.12
CRP  is  a  classic  and  highly  sensitive  acute  phase  protein
hose  plasma  levels  typically  increase  100  times  or  more
uring  inﬂammation.  CRP  is  a  strong  predictor  for  cardio-
ascular  risk  and  indirect  evidence  indicates  that  it  can  be
irectly  related  to  atherosclerosis.13
Our  hypothesis  was  that  the  patients  that  underwent
ariatric  surgery  would  present  with  signiﬁcant  CRP  reduc-
ion  6  months  after  the  procedure.
The  principal  aim  of  this  study  was  to  establish  the  base-
ine  CRP  values  and  then  those  at  6  months  after  bariatric
urgery,  as  well  as  the  changes  in  weight,  body  mass  index
BMI),  leukocytes,  and  glycemia.  Another  aim  was  to  deter-
ine  whether  there  was  any  correlation  between  CRP  values
nd  weight,  BMI,  leukocytes,  and  glycemia.
ethods
n  open,  analytic,  observational,  longitudinal,  and  retro-
pective  study  was  conducted.  It  included  patients  seen
t  the  Hospital  General  Dr.  Manuel  Gea  González  that
ere  diagnosed  with  morbid  obesity.  They  underwent
ariatric  surgery  within  the  time  frame  of  January  2009
o  January  2012.  The  inclusion  criteria  were  patients  diag-
osed  with  morbid  obesity  with  no  comorbidities,  surgically
reated  with  gastric  by-pass  or  sleeve  gastrectomy  and
reated  at  the  abovementioned  hospital,  and  whose  medi-
al  records  included  measurements  of  weight,  glycemia,
eukocytes,  and  CRP  at  the  baseline  and  6  months  after
urgery.
The  baseline  CRP,  leukocyte,  and  glucose  measurements
ere  determined  at  7:00  h  the  day  of  the  surgery,  prior  to
he  procedure,  provided  that  the  patients  had  agreed  to
nroll  in  the  study  and  had  signed  statements  of  informed
onsent.
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vLeukocytes  (x103/mm3)  8.62  ±  1.69
BMI: Body mass index; CRP: C-reactive protein.
The  SYNCHRON  LX  system  was  used  for  measuring  CRP  by
 turbidimetric  method.  In  the  reaction,  CRP  is  combined
ith  a speciﬁc  antibody  to  form  insoluble  antigen-antibody
omplexes.  The  system  controls  the  change  of  absorbance
t  340  nanometers,  which  is  directly  proportional  to  the  CRP
ample  concentration  and  is  used  for  calculating  the  concen-
ration,  based  on  a  predetermined  calibration  curve  and  a
ingle  point.
Patients  that  had  been  operated  on  at  a  different  hos-
ital  or  that  did  not  have  the  baseline  and  postoperative
RP  measurements  were  excluded  from  the  study.  A  sample
ize  of  36  patients  was  calculated  and  a detected  correla-
ion  coefﬁcient  of  at  least  0.4  was  expected,  with  a  95%
onﬁdence  interval  and  an  80%  test  potential  (Epidat  4.0).
The  case  records  of  the  study  population  were  reviewed.
 database  was  formed  that  included  the  sex  and  age  of
he  patients,  the  type  of  surgery  performed,  patient  weight,
eight,  and  BMI,  white  blood  cells,  and  glycemia,  along  with
he  preoperative  CRP  and  the  postoperative  CRP  at  6  months
fter  surgery.  The  difference  between  the  baseline  variables
nd  those  at  6  months  was  analyzed,  as  well  as  the  correla-
ion  of  CRP  with  weight,  BMI,  glycemia,  and  leukocytes.  The
xisting  linear  correlation  between  CRP  and  weight,  BMI,
lucose,  and  leukocytes  was  determined  using  the  Pearson
orrelation  coefﬁcient.
The  statistical  analysis  was  done  with  the  Excel  and
tatCalc  programs  and  means  ±  standard  deviation  were
btained.  The  differences  between  the  baseline  and  post-
perative  values  at  6  months  were  analyzed  using  the  paired
tudent’s  t  test.  The  Pearson  correlation  coefﬁcient  was
mployed  to  determine  the  correlation  between  the  varia-
les.  Statistical  signiﬁcance  was  considered  when  p  <  0.05.
esults
 total  of  36  patients  were  included  in  the  study.  All  the
atients  without  comorbidities  that  underwent  bariatric
urgery  within  the  time  frame  described  accepted  to  partic-
pate  in  the  study  and  their  baseline  CRP  and  postoperative
RP  values  at  6  months  were  measured.  The  preoperative
ariables  are  shown  in  Table  1.
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Table  2  Comparison  of  preoperative  and  post-operative  values  (n  =  36).
Variables  Preoperative
Mean  ±  SD
Post-operative  (6  months)
Mean  ±  SD
p
CRP  (mg/l)  1.15  ±  0.86  0.34  ±  0.28  0.0001
Weight (kg)  112.10  ±  22.91  84.82  ±  17.11  0.0443
BMI (kg/m2) 42.48  ±  5.97  32.2  ±  4.79  0.0988
Glucose (mg/dl) 100.58  ±  17.82 87.11  ±  8.49 0.0001
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SD: standard deviation; BMI: body mass index; CRP: C-reactive pr
The  preoperative  and  postoperative  values  of  the  varia-
bles  were  compared,  as  shown  in  Table  2.  There  was  a
statistically  signiﬁcant  decrease  between  the  preoperative
and  the  postoperative  values  of  CRP,  weight,  and  fasting  glu-
cose.  The  mean  percentage  of  the  CRP  decrease  between
the  preoperative  value  and  that  at  6  months  after  surgery
was  65%.  Despite  the  fact  that  there  was  a  decrease  in  the
BMI  in  relation  to  the  preoperative  and  postoperative  val-
ues  (42.48  and  32.2,  respectively),  there  was  no  statistical
signiﬁcance;  with  a  larger  sample  size  a  p  <  0.05  probably
would  have  been  reached.
The  preoperative  CRP  correlation  coefﬁcient  with  the
variables  analyzed  was:  weight  r  =  0.33,  p  =  0.047  (Fig.  1);
BMI  r  =  0.37,  p  =  0.027  (Fig.  2);  glucose  r  =  0.30,  p  =  0.071;  and
leukocytes  r  =  0.03,  p  =  0.22;  the  ﬁrst  2  values  were  statis-
tically  signiﬁcant.  The  CRP  and  postoperative  variables  did
not  show  high  correlation  coefﬁcients.
Discussion
Six  months  after  surgery  there  was  a  considerable  decrease
in  CRP;  the  mean  value  was  0.34  mg/l,  which  was  within  the
normal  range.  The  difference  with  respect  to  the  baseline
value  was  statistically  signiﬁcant.  There  were  also  statisti-
cally  signiﬁcant  decreases  in  weight  and  glucose  after  the
surgery.  The  decrease  in  the  leukocyte  value  was  not  sig-
niﬁcant,  nor  was  it  correlated  with  the  CRP  values.  The
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Figure  1  The  linear  correlation  between  baseline  weight  and  CR6.99  ±  1.56 0.3192
.
orrelation  of  the  baseline  values  of  CRP  with  weight  and
MI  was  statistically  signiﬁcant.
The  mean  of  the  CRP  baseline  value  of  1.15  mg/l  was
bove  the  normal  value,  which  according  to  laboratory  stan-
ards  and  the  turbidimetric  methods  used  in  the  SYNCHRON
X,  should  be  <  0.8  mg/l.  Moreover,  the  mean  glucose  value
as  100.58,  slightly  above  the  upper  limit  of  the  test.
There  were  no  signiﬁcant  differences  in  the  results
ccording  to  the  type  of  surgery  performed.  Therefore,  the
ata  analysis  was  carried  out  using  the  sample  total.
The  Pearson  correlation  coefﬁcient  between  variables
oes  not  show  a  cause-and-effect  relation,  but  rather  the
egree  of  intensity  of  the  possible  relation  between  the
ariables.  In  the  present  case,  the  relation  between  the
reoperative  values  of  CRP  and  weight  and  CRP  and  BMI
as  linear  and  statistically  signiﬁcant  (Figs.  1  and  2).  The
orrelation  coefﬁcient  between  CRP  and  glucose  was  not
tatistically  signiﬁcant,  which  was  probably  due  to  the  sam-
le  size,  but  there  was  a  linear  correlation  between  them.
here  was  no  linear  relation  between  CRP  and  leukocytes  or
etween  CRP  and  the  postoperative  variables,  which  could
e  because  the  postoperative  CRP  changes  were  multifac-
orial  and  had  no  direct  relation  with  the  study  variables.
urthermore,  the  postoperative  CRP  values  were  within  nor-
al  ranges  and  so  its  sensitivity  as  an  inﬂammation  marker
t  that  particular  moment,  was  probably  low.
Given  that  the  preoperative  leukocyte  values  were  not
igh,  their  postoperative  values  were  not  expected  to
.5
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3.53 4.54 5
P  in  the  36  study  patients  is  shown.  CRP:  C-reactive  protein.
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ligure  2  The  linear  correlation  between  baseline  BMI  and  CR
ody mass  index.
ecrease  signiﬁcantly.  There  is  no  evidence  that  they  are
hronic  inﬂammation  markers,  but  their  values  are  high  in
cute  inﬂammatory  processes.
There  is  little  reported  in  the  literature  on  the  decrease
f  CRP  after  bariatric  surgery  in  Mexican  patients.  Her-
era  et  al.14 studied  the  effect  of  omentectomy  on  bariatric
urgery  and  as  a  secondary  aim,  they  measured  the  baseline
nd  postoperative  CRP  values  in  22  patients.  They  found  no
ifferences  in  performing  omentectomy  or  not;  a  decrease
n  CRP  was  documented  in  both  groups,  but  it  was  not  sta-
istically  signiﬁcant.  In  contrast,  in  the  present  study,  the
umber  of  patients  studied  was  over  50%  higher  (n  =  36)
nd  the  difference  in  preoperative  and  postoperative  CRP
as  statistically  signiﬁcant.  In  addition,  there  was  a  statis-
ically  signiﬁcant  preoperative  linear  correlation  between
RP  and  weight  and  BMI.  Without  a  doubt,  both  studies
rovide  some  preliminary  evidence  in  relation  to  inﬂamma-
ion  and  bariatric  surgery  in  obese  patients  in  the  Mexican
opulation.  The  similarities  and  differences  in  the  behavior
f  the  inﬂammation  mediators  among  this  population  and
thers  that  have  been  widely  studied  in  this  respect  remain
o  be  explained.
Numerous  studies  on  other  populations  worldwide  have
hown  a  decrease  in  CRP  after  bariatric  surgery.  Agrawal
t  al.15 conducted  a  retrospective  study  on  a  sample  of  62
bese  patients  in  which  they  evaluated  the  decrease  in  albu-
inuria  and  CRP  levels  after  bariatric  surgery.  They  found
 statistically  signiﬁcant  decrease  of  both  values  that  was
irectly  proportional  to  weight  loss.  In  our  study,  there  was  a
tatistically  signiﬁcant  correlation  between  the  baseline  val-
es  of  CRP  and  weight  and  BMI,  but  not  in  the  values  at  6
onths  after  surgery.  As  we  have  already  mentioned,  it  was
nteresting  that  there  was  no  postoperative  linear  correla-
ion  between  these  variables,  reﬂecting  the  different  and
omplex  factors  that  intervene  in  the  decrease  of  CRP  values
fter  bariatric  surgery.
There  are  other  inﬂammation  mediators  that  have  been
tudied  postoperatively  in  gastric  bypass  patients.  Orea
t  al.16 conducted  a  prospective  study  on  50  obese  patients,
t
i
a
p the  36  study  patients  is  shown.  CRP:  C-reactive  protein;  BMI:
easuring  the  serum  concentrations  of  CRP  and  ICAM-1,
efore  bariatric  surgery  and  at  3,  6,  and  12  months  after  the
rocedure,  and  found  a signiﬁcant  decrease  in  both  values.
n  the  other  hand,  Illán  et  al.17 measured  the  serum  val-
es  of  adiponectin,  CRP,  TNF, and  IL-6  in  60  obese  patients
efore  laparoscopic  gastric  bypass  surgery  and  at  6  and  12
onths  after  the  procedure;  they  found  an  increase  in  anti-
nﬂammatory  factor  adiponectin  and  a  signiﬁcant  decrease
n  IL-6  and  CRP,  but  not  in  TNF. Likewise,  Pardina  et  al.18
ound  that  the  decrease  in  TNF after  bariatric  surgery  was
ot  signiﬁcant,  whereas,  CRP  was  statistically  signiﬁcant
n  serum,  as  well  as  in  tissue.  In  addition,  Saleh  et  al.19
orroborated  the  signiﬁcant  decrease  in  CRP  and  glucose
n  a  study  conducted  on  non-diabetic  obese  patients.  They
lso  observed  a  decrease  in  the  carotid  artery  intima-media
hickness  and  improvement  in  lipid  metabolism.
It  should  be  emphasized  that  in  the  present  study,
urgery  achieved  a  65%  decrease  in  the  baseline  CRP  lev-
ls  at  6  months  after  the  procedure.  In  a  meta-analysis  by
aghavendra,20 published  in  2012,  they  included  observa-
ional  studies  that  evaluated  changes  in  CRP,  TNF, and
L-6  in  obese  patients  after  bariatric  surgery.  There  was  a
ecrease  in  the  CRP  values  of  66%,  which  was  very  similar
o  what  we  reported,  as  well  as  a  27%  decrease  in  IL-6,  and
 non-signiﬁcant  decrease  in  TNF.
onclusions
RP  had  a  signiﬁcant  preoperative  linear  relation  to  weight
nd  BMI.  The  patients  studied  that  underwent  gastric  bypass
nd  sleeve  gastrectomy  procedures  presented  with  a  signif-
cant  postoperative  decrease  in  CRP,  weight,  and  glucose
alues.  There  are  many  likely  factors  that  intervene  in  CRP
eduction  after  bariatric  surgery  and  their  relation  is  non-
inear.  Further  studies  are  needed  to  corroborate  whether
he  decrease  in  CRP  as  a  marker  of  a  proinﬂammatory  state
s  related  to  a  decrease  in  the  incidence  of  other  diseases
nd  to  a  reduced  risk  for  cardiovascular  disease  in  these
atients.
nd  a
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1C-Reactive  protein  level  in  morbidly  obese  patients  before  a
Financial disclosure
No  ﬁnancial  support  was  received  in  relation  to  this  article.
Conﬂict of interest
The  authors  declare  that  there  is  no  conﬂict  of  interest.
References
1. Kumanyika SK, Obarzanek E, Stettler N. Population-based pre-
vention of obesity: the need for comprehensive promotion of
healthful eating, physical activity, and energy balance: A sci-
entiﬁc statement from American Heart Association Council on
Epidemiology and Prevention, Interdisciplinary Committee for
prevention (formerly the expert panel on population and pre-
vention science). Circulation. 2008;118:428--64.
2. Fired M, Hainer V, Basdevant A. Inter-disciplinary european
guidelines on surgery of severe obesity. Int J Obes (Lond).
2007;31:569--77.
3. Jain A. Treating obesity in individuals and populations. BMJ.
2005;331:1387--90.
4. Hukshorn C, Lindeman JH, Toet KH. Leptin and the proinﬂam-
matory state associated with human obesity. J Clin Endocrinol
Metab. 2004;89:1773--8.
5. Hevener AL, Febbraio MA. The 2009 stock conference report:
Inﬂammation, obesity and metabolic disease. Obes Rev.
2010;11:635--44.
6. Lee YH, Pratley RE. The evolving role of inﬂammation in obe-
sity and the metabolic syndrome. Current Diabetes Reports.
2005;5:70--5.
7. Shoelson SE, Herrero L, Naaz A. Obesity, inﬂammation, and
insulin resistance. Gastroenterology. 2007;132:2169--80.
8. Vazquez LA, Pazos F, Berrazueta JR. Effects of changes in body
weight and insulin resistance on inﬂammation and endothe-
lial function in morbid obesity after bariatric surgery. J Clin
Endocrinol Metab. 2005;90:316--22.
9. Needleman BJ, Happel NC. Bariatric surgery: Choosing the opti-
mal procedure. Surg Clin North Am. 2008;88:991--1007.
2fter  bariatric  surgery  95
0. Van Dielen FM, Buurman WA, Hadfoune M. Macrophage
inhibitory factor, plasminogen activator inhibitor-1, other acute
phase proteins, and inﬂammatory mediators normalize as
a result of weight loss in morbidly obese subjects treated
with gastric restrictive surgery. J Clin Endocrinol Metab.
2004;89:4062--8.
1. Appachi S, Kashyap SR. Adiposopathy and cardiovascular dis-
ease: The beneﬁts of bariatric surgery. Curr Opin Cardiol.
2013;28:540--6.
2. Vest AR, Heneghan HM, Agarwal S. Bariatric surgery and
cardiovascular outcomes: A systematic review. Heart.
2012;98:1763--77.
3. Mahadik SR, Deo SS, Mehtalia SD. Association of adiposity,
inﬂammation and atherosclerosis: The role of adipocytokines
and CRP in Asian Indian subjects. Metab Syndr Relat Disord.
2008;6:121--8.
4. Herrera MF, Pantoja JP, Velázquz-Fernández D. Potential
additional effect of omentectomy on metabolic syndrome,
acute-phase reactants, and inﬂammatory mediators in grade
iii obese patients undergoing laparoscopic Roux-en-Y gas-
tric bypass: A randomized trial. Diabetes Care. 2010;33:
1413--8.
5. Agrawal V, Krause K, Chengelis D. Relation between degree
of weight loss after bariatric surgery and reduction in albu-
minuria and C-reactive protein. Surg Obes Relat Dis. 2009;5:
20--6.
6. Orea I, Illán F, González M. Moléculas solubles de adhesión
intercelular tipo 1 y proteína C reactiva tras cirugía bariátrica.
Endocrinol Nutr. 2010;57:90--4.
7. Illán F, González M, Orea I, Alcaraz-Tafalla MS. Obesity and
Inﬂammation: Change in adiponectin, C-reactive protein, tumor
necrosis factor-alpha and interleukin-6 after bariatric surgery.
Obes Surg. 2012;22:950--5.
8. Pardina E, Ferrer R, Baena-Fustegueras J. Only C-reactive
protein, but not TNF- or IL6, reﬂects the improvement in
inﬂammation after bariatric surgery. Obes Surg. 2012;22:131--9.
9. Saleh MH, Bertolami MC, Assef JE. Improvement of atheroscle-
rotic markers in non-diabetic patients after bariatric surgery.
Obes Surg. 2012;22:1701--7.
0. Raghavendra S. Inﬂammatory markers and bariatric surgery:
A meta-analysis. Inﬂamm Res. 2012;61:789--807.
